JAMA Review Links Obesity to 12 Cancers as 40% of Cases Are Lifestyle-Related
Updated
Updated · The Hastings Tribune · Jun 11
JAMA Review Links Obesity to 12 Cancers as 40% of Cases Are Lifestyle-Related
3 articles · Updated · The Hastings Tribune · Jun 11
Summary
An April 21 JAMA review says obesity raises the risk of at least 12 cancers and may contribute to about 10% of all cancer cases.
The review frames that link within a broader finding that nearly 40% of cancers are lifestyle-related and therefore potentially preventable, with tobacco still the leading modifiable cause.
The 12 obesity-related cancers listed by the International Agency for Research on Cancer include colorectal, postmenopausal breast, kidney, liver, pancreatic and endometrial cancers, with additional associations seen in prostate cancer and melanoma.
White adipose tissue helps explain the risk: it produces estrogen and other hormones, promotes inflammation, and can impair immune detection of tumor cells and DNA repair.
The report warns U.S. obesity could reach 49% of adults by 2030, up from 42% in 2020, while citing diet, exercise, surgery and GLP-1 drugs as ways to cut risk.
As obesity rates approach 50% in the U.S., are we on the brink of a massive, preventable cancer wave?
Is your waistline a more accurate predictor of cancer risk than your BMI? New research challenges the standard metric.
Do popular weight-loss drugs have a secret power to directly fight cancer cells, beyond just shedding pounds?
Obesity and Cancer in 2026: The Alarming Surge, Biological Mechanisms, and Urgent Pathways for Prevention
Overview
This report highlights how global economic development, urbanization, and changes in diet and physical activity are driving a worldwide surge in body mass index (BMI), making obesity a major global health challenge. As obesity rates rise, especially in low- and middle-income countries, the risk and burden of various cancers are increasing rapidly. The report explains that excess body fat not only raises the chance of developing cancer but also worsens outcomes for those diagnosed, affecting prognosis and response to treatment. These findings underscore the urgent need for public health action to address obesity and its impact on cancer worldwide.